Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹137Prev. Close
₹132Turnover(Lac.)
₹10.36Day's High
₹146Day's Low
₹13752 Week's High
₹172.852 Week's Low
₹87.1Book Value
₹45.76Face Value
₹10Mkt Cap (₹ Cr.)
159.12P/E
27.69EPS
5.2Divi. Yield
011 Aug 2023
12:00 AM
AGM
Announcement Date: 11 Aug, 2023
9 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 17.52 | 2.3 | 2.3 | 2.3 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3.47 | 4.8 | 2.51 | 1.39 |
Net Worth | 20.99 | 7.1 | 4.81 | 3.69 |
Minority Interest |
No Record found
No Record found
No Record found
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Gross Sales | 103.83 | 77.48 | 48.84 | 28.6 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 103.83 | 77.48 | 48.84 | 28.6 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 0.49 | 0.93 | 0.11 | 0.22 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,525.25 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,561.05 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,484.1 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,092.55 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,492.3 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Sharadkumar Dashrathbhai Patel
Whole-time Director
Dineshkumar Babulal Gelot
Executive Director
Vishalkumar Devrajbhai Patel
Executive Director
Chetankumar Bachubhai Patel
Independent Non Exe. Director
Ms. Nidhiben Patel
Independent Non Exe. Director
Hetal Umangbhai Shah
Independent Non Exe. Director
Heena Viral Patel
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Sotac Pharmaceuticals Ltd
Summary
Sotac Pharmaceuticals Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name of M/s Sotac Pharmaceuticals, pursuant to a Deed of Partnership dated October 28, 2015. Thereafter M/s. Sotac Pharmaceuticals was converted from Partnership Firm to a Private Limited Company in the name of Sotac Pharmaceuticals Private Limited dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat. Later on, Company converted into a Public Limited Company and the name of Company was changed to Sotac Pharmaceuticals Limited dated November 22, 2022 issued by Registrar of Companies, Ahmedabad.The Company is a part of SOTAC Group, based at Gujarat and is engaged in manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. The Company is pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products such as Non Beta-Lactam (general) tablets, beta-lactam coated tablets, beta-lactam uncoated tablets, Non Beta-Lactam (general) capsules, beta-lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray and cream. The Companys therapeutic portfolio include Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, AntiAllergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, AntiPyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibioti
Read More
What is the Sotac Pharmaceuticals Ltd share price today?
The Sotac Pharmaceuticals Ltd shares price on nse is Rs.₹144 today.
What is the Market Cap of Sotac Pharmaceuticals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sotac Pharmaceuticals Ltd is ₹159.12 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Sotac Pharmaceuticals Ltd?
The PE and PB ratios of Sotac Pharmaceuticals Ltd is 27.69 and 3.30 as of 03 Jul ‘24
What is the 52 Week High and Low of Sotac Pharmaceuticals Ltd?
The 52-week high/low is the highest and lowest price at which a Sotac Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Sotac Pharmaceuticals Ltd is ₹87.1 and ₹172.8 as of 03 Jul ‘24
What is the CAGR of Sotac Pharmaceuticals Ltd?
Sotac Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 10.92%, 6 Month at 6.54%, 3 Month at -1.49% and 1 Month at 14.78%.
What is the shareholding pattern of Sotac Pharmaceuticals Ltd?
The shareholding pattern of Sotac Pharmaceuticals Ltd is as follows:
Promoters - 72.85 %
Institutions - 8.99 %
Public - 18.16 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
